Vaximm (Germany)

Recent papers from Vaximm (Germany)

1. Glycan-dependent cell adhesion mechanism of Tc toxinsNature Communications · 2020
2. A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancerSHILAP Revista de lepidopterología · 2017
3. Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trialOncoImmunology · 2015
4. Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancerBMC Cancer · 2012